Akoya Biosciences (AKYA)
(Delayed Data from NSDQ)
$2.31 USD
+0.06 (2.67%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $2.31 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum F VGM
Price, Consensus and EPS Surprise
AKYA 2.31 +0.06(2.67%)
Will AKYA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AKYA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AKYA
Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Lags Revenue Estimates
AKYA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Tops Revenue Estimates
Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates
Other News for AKYA
Akoya Biosciences: Poised for Growth in Spatial Biology and Precision Medicine
Craig-Hallum starts Akoya with a Buy, says shares 'significantly' undervalued
Akoya Biosciences initiated with bullish view at Craig-Hallum
Akoya Biosciences management to meet virtually with BTIG
Akoya Biosciences management to meet virtually with BTIG